3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Interventions
Cyclophosphamide
23
fludarabine
15
fludarabine phosphate
10
Methotrexate
10
blinatumomab
9
Whole-Body Irradiation
9
Vincristine
7
Specimen Handling
7
Dexamethasone
7
merphos
6
Tacrolimus
6
Mycophenolic Acid
6
Stem Cell Transplantation
5
Peripheral Blood Stem Cell Transplantation
5
Mesna
5
Mercaptopurine
5
Melphalan
5
Leukapheresis
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Cytarabine
5
Cyclosporine
5
Biopsy
5
pegaspargase
4
Prednisone
4
Magnetic Resonance Spectroscopy
4
Etoposide
4
Calcium Dobesilate
4
Busulfan
4
prednylidene
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
posaconazole
×
30 days
×
Clear all
NCT07155226
2026-05-19
MOMENTUM
AstraZeneca
Phase 1/2
Recruiting
84 enrolled